The effect of ventromedial tegmental lesions on the disposition and biosynthesis of dopamine and serotonin.
D000311:Adrenal Glands / Q000201:enzymology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002262:Carboxy-Lyases / Q000378:metabolism; D002421:Caudate Nucleus / Q000378:metabolism; D003342:Corpus Striatum / Q000201:enzymology / Q000378:metabolism*; D004296:Dopa Decarboxylase / Q000302:isolation & purification / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D000882:Haplorhini; D006651:Histocytochemistry; D006892:Hydroxydopamines / Q000494:pharmacology; D007120:Immunochemistry; D009474:Neurons / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism*; D013681:Tegmentum Mesencephali / Q000502:physiology*; D014202:Tremor / Q000188:drug therapy; D014316:Tritium
D000978:Antiparkinson Agents; D002250:Carbon Radioisotopes; D006892:Hydroxydopamines; D014316:Tritium; D012701:Serotonin; D002262:Carboxy-Lyases; D004296:Dopa Decarboxylase; D004298:Dopamine